Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Autologous nanofat transfer: Fat is extracted from patients thigh under local anaesthesia and tumescent anaesthesia and converted into nanofat which is injected into bald areas of alop
Sponsors
Varsha M
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient willing to give written informed consent (Annexure 1a, 1b, 1c) 2. Patients above 18 years of age and either sex 3. Patients with clinically and dermoscopically diagnosed as Androgenetic alopecia 4. Patients with BMI < 40kg/m2
Exclusion criteria
Exclusion criteria: 1. Patient not willing to give written informed consent 2. Pregnant and lactating women 3. Patients with BMI 4. Patients currently suffering from an active autoimmune disease like SLE, Alopecia aerata 5. Patients suffering from any cardiovascular, renal, hematological, pulmonary, gastrointestinal or central nervous system disorders. 6. Patients with any bleeding or clotting disorders or on antiplatelet therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trichoscopic improvement in hair density and hair diameterTimepoint: Baseline, 1 month, 2 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in Visual analogue scale Improvement in global photographyTimepoint: 12 months | — |
Countries
India
Contacts
Public ContactVarsha M
Bangalore Medical College and Research Institute
Outcome results
None listed